Skarp. For investors.

Skarp is a premium subscription supplement brand launching Q4 2026. We're building the daily morning compound for builders, founders, and operators in the EU and beyond. Opening our first round to operators, angels, and strategic partners who understand consumer brand building.

Why now.

The global supplements market is over 150 billion dollars and growing double digits annually. Three trends converge in our window.

Daily compound subscriptions have proven scalable. Athletic Greens reached a 1.2 billion dollar valuation on a single SKU. LMNT crossed 200 million in revenue. Momentous, Bulletproof, and Magic Spoon have built nine-figure businesses on the same playbook.

EU is underserved. The biggest brands in the category are American. The European premium morning compound category has no clear winner. We launch from inside the EU with EU grade supply chain, EU compliance, and EU pricing.

The customer profile is sharp and underserved. AG1 owns the optimizer. LMNT owns the keto athlete. Nobody owns the 25 to 35 year old founder, operator, or maker who is climbing toward financial independence and treats every morning as a compounding decision. This is our customer.

What we're building.

Skarp is a premium daily compound. Eleven clinically dosed ingredients in one scoop, designed to be taken before the first cup of coffee. 30 servings per jar, monthly subscription.

Built around four functional pillars.

Sustained mental sharpness. B-vitamins (B6, B12, folate) and magnesium are clinically established to reduce tiredness and fatigue and support normal psychological function. The customer experiences clearer mornings and steadier focus through the day.

Physical and cognitive endurance. Creatine monohydrate (5g Creapure) is one of the most studied compounds in human performance science, with extensive research on both muscular and cognitive endurance. L-theanine and rhodiola are included as premium adaptogens with long histories of use in stress and performance contexts.

Hydration and morning recovery. Sodium, potassium, and magnesium replenish overnight electrolyte loss before coffee compounds dehydration. The customer starts the day hydrated, not behind.

Long-term foundation. D3, K2 (MK-7), B12 (methylcobalamin), and folate (5-MTHF) target the daily nutrient gaps most common in high-performing adults under chronic stress. Customers compound benefits over weeks and months, not days.

Sourced and built right. Every ingredient from premium suppliers including Creapure for creatine and Reb M for stevia. Built within the EU regulatory framework with all health claims aligned to EFSA permitted statements. No proprietary blends. Every milligram on the label.

The product, formula, and flavors are locked. Brand, positioning, and waitlist are live. Manufacturing partner selection is in progress.

Why it wins.

Category creation. Skarp is not a greens brand, not a pre-workout, not a nootropic. We're naming a new category called the daily compound and positioning Skarp at the top of it. First mover advantage in a category we define.

Brand precision. Premium Nordic design. Real doses on the label. No proprietary blends. No celebrity endorsements. The customer who reads ingredient labels has the highest LTV in this category, and the brand is built to convert that customer specifically.

Built for subscription from day one. Single SKU, single price point, monthly cadence. Same playbook that took AG1 to a billion dollar valuation, applied to a sharper customer.

Why us.

Most consumer brands burn their first round on customer acquisition costs and creator outreach. Skarp does not.

Built in acquisition infrastructure. The founding team operates an organic content agency in Helsinki that has taken dozens of Finnish e-commerce brands viral, with an active creator network across the Nordics. Skarp launches with content production, creator relationships, and paid acquisition partnerships already in place.

DTC operating experience. The founder has been operating in direct response marketing & e commerce for eight years, currently runs a profitable luxury sofa e-commerce brand built end to end, and has direct experience with international manufacturing, premium pricing, and unit economics that work at scale.

Speed to launch. Most consumer brand pre-seed rounds fund 18 to 24 months of work before first revenue. Skarp's round is structured to deliver paying subscribers within 9 to 12 months of close.

Founder.

Sulo Mäki. Eight years operating in direct response marketing, brand building, and e-commerce. Currently owns and runs Sohvakotiin.fi, a profitable luxury sofa e-commerce brand built end to end including brand, supply chain, and overseas manufacturing relationships. Also operates a Helsinki-based organic content agency on track to break 500k in revenue in its first fiscal year, with a creator network spanning the Nordics. Previously founded and exited a Helsinki recruitment business.

Native English. Operates internationally. Sole operating founder.

Use of funds.

The first round funds the path from current state to first paying subscribers and validated unit economics. Capital allocation:

1. First production run. Inaugural batch of Skarp jars in EU grade facilities. Premium ingredients including Creapure creatine, Reb M stevia, clinically dosed B-vitamins, and adaptogens.

2. Brand and IP protection. EU and US trademark filings in Class 5 and Class 32, packaging finalization, and legal compliance review.

3. Growth and influencer network. Building Skarp's founding partner program and scaling the creator network across the Nordics and EU. Supported by in-house organic content production and a paid acquisition partner. Building a sustainable customer acquisition cost from launch.

4. Founding team. Formalizing key roles in product, brand, and growth as the company scales past launch.

Detailed budget split, timeline, and milestone structure are in the deck.

Who we're talking to.

This round is open to a small group of:

Operators with hands on experience scaling DTC consumer brands or subscription e-commerce.

Angels with backgrounds in CPG, supplements, wellness, or premium consumer.

Strategic partners with relevant distribution, retail, or manufacturing relationships in the EU or globally.

We are not raising from institutional VCs at this stage. We are raising from people who have done this before and can move quickly.

Frequently asked.

Round size?
Discussed individually with serious investors.

Structure?
SAFE or convertible note. Terms discussed individually.

Close timing?
Rolling close through Q3 2026.

Cap table?
Founder controlled. Full details shared during diligence.

Geography?
Open to investors in the EU, UK, US, and beyond, subject to fit.

Deck?
Available on request after a brief introduction.

We are not raising from institutional VCs at this stage. We are raising from people who have done this before and can move quickly.

Request the deck.

Tell us a bit about you. We respond personally to every serious inquiry within five business days.